
Hypno VR
Developing virtual reality-based medical hypnosis solutions.
- dt and ls
- horizon europe
- radar de l'innovation
- tech for business
- developer tools
- immersive technologies
- eit ecosystem
- observatoire deeptech
- mental health
- digital care
- eit health
- biotech, medtech and e-health
- psychology
- digital therapeutics
- investor network (eit health)
- living labs and test beds (eit health)
- living labs and test beds 2020 (eit health)
- investor network 2020 (eit health)
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | €4.5m | Series A | |
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 1400 % | 373 % | 194 % | 35 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
HypnoVR, established in 2016 by co-founders Nicolas Schaettel, Denis Graff, and Chloé Chauvin, operates at the intersection of healthcare and technology, offering a digital therapy that leverages virtual reality to manage pain and anxiety. The company's genesis stems from the direct clinical experience of its founders, two of whom are anesthesiologists and hypnotists, who sought a non-pharmacological method for patient care. This background provides the company with a deep-rooted understanding of the clinical environments its product is designed for.
The core of HypnoVR's business is a CE-marked medical device that delivers therapeutic hypnosis sessions through a virtual reality headset. This product is designed to reduce patient stress and discomfort before, during, and after medical procedures such as surgery, dental work, oncology treatments, and medically assisted procreation. Clinical studies have indicated the effectiveness of this approach, with results showing a significant reduction in patient anxiety and a decrease in the need for sedative or anesthetic drugs. The technology creates a multi-sensory immersive experience, combining hypnotic audio scripts with captivating visuals to distract patients and induce a state of calm.
HypnoVR targets healthcare institutions, including hospitals and private clinics, as its primary client base. The business model appears to be centered on the sale or subscription of their VR kits, which include the headset, software, and necessary accessories, designed to integrate smoothly into existing clinical workflows and meet stringent hygiene standards. The company has secured distribution through major healthcare purchasing groups in France, such as UniHA and UGAP, facilitating its adoption within the French healthcare system. Having raised over €5 million in funding since its inception, the company is focused on expanding its market presence across Europe and advancing its therapeutic software.
Keywords: digital therapeutics, medical VR, pain management, anxiety reduction, medical hypnosis, non-pharmacological treatment, anesthesiology, digital health, MedTech, clinical VR
Tech stack
Investments by Hypno VR
Edit